Skip to content
AwardedSpainGoods€37,832,054

Suministro de medicamentos de uso humano cuyos principios activos son Mifamurtida, Vedolizumab y Marivabir, con destino a los centros del ámbito de la Sanidad Pública Valenciana.

Published
Published 2 July 2025

Overview

Suministro de medicamentos de uso humano cuyos principios activos son Mifamurtida, Vedolizumab y Marivabir, con destino a los centros del ámbito de la Sanidad Pública Valenciana.

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€37,832,054
Procedure
Direct
Published
2 July 2025
Classification (CPV)
Antivirals for systemic useAntineoplastic and immunomodulating agentsImmunosuppressive agents

Award outcome

Awarded value
€9,007,632
Award date
28 May 2025
Winner
  • TAKEDA FARMACÉUTICA ESPAÑA S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    2 July 2025

Contracting authority

  • Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad

    Procuring entity

    Valencia, Spain

    ID_PLATAFORMA: 20897030133463

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro de medicamentos de uso humano cuyos principios activos son Mifamurtida, Vedolizumab y Marivabir, con destino a los centros del ámbito de la Sanidad Pública Valenciana. — won by TAKEDA FARMACÉUTICA ESPAÑA S.A. — Skim